Activated Checkpoint Kinase 2 Expression and Risk for Oral Squamous Cell Carcinoma
Authors:
Open Access
- 1 December 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 16 (12) , 2768-2772
Abstract
Background: Phosphoactivation of a DNA damage response molecule checkpoint kinase 2 (pChk2) may be a marker of oral epithelial cells that have entered the precancerous and squamous cell carcinoma (SCC) stages. We explored whether there was selective expression of pChk2 in precancerous lesions but not in nonneoplastic tissue of the oral mucosa. Experimental Design: In a retrospective cohort design, 96 biopsied clinical leukoplakias and erythroplakias with known subsequent progression to SCC were identified from 48 subjects and assigned as the cases group. Expression status of pChk2 was compared with that of the 97 leukoplakias and erythroplakias that did not progress to SCC (control groups) by immunohistochemical analysis. Included in both groups were lesions with histologically confirmed dysplasia and those that lacked histologic evidence of atypia. Results: Subjects with pChk2-positive but histology-negative (for atypia) lesions had an 8.6 times higher risk of developing SCC compared with those with pChk2-negative and histology-negative lesions. Overall, the presence of detectable pChk2 staining was able to identify lesions at risk of developing SCC within 3 years with a sensitivity of 85.2%, specificity of 74.2%, and predictive accuracy of 78.2% (odds ratio, 19.9; 95% confidence interval, 7.3-55.5). Conclusion: This is the first study to include histologically nonatypical cases in the analysis of a putative biomarker for oral precancerous lesions. Our data show that pChk2 merits further investigation as a promising biomarker that can discriminate those lesions at risk for developing SCC, regardless of histologic evidence for atypia. (Cancer Epidemiol Biomarkers Prev 2007;16(12):2768–72)Keywords
This publication has 13 references indexed in Scilit:
- Clinical implications and utility of field cancerizationCancer Cell International, 2007
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- The Chk2 protein kinaseDNA Repair, 2004
- Chemoprevention of CancerCA: A Cancer Journal for Clinicians, 2004
- Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence ?Oral Oncology, 2004
- Prognosis of Oral Pre-malignant Lesions: Significance of Clinical, Histopathological, and Molecular Biological CharacteristicsCritical Reviews in Oral Biology & Medicine, 2003
- Potentially malignant oral lesions in Northern Ireland: a 20-year population-based perspective of malignant transformationOral Diseases, 2001
- Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10‐year follow‐up study of Indian villagersCommunity Dentistry and Oral Epidemiology, 1980
- The contribution of dentifrices to oral health: the futureCommunity Dentistry and Oral Epidemiology, 1980